Stockholders’ Deficit (Details)	1 Months Ended			3 Months Ended	6 Months Ended		12 Months Ended
	Apr. 30, 2020 USD ($) shares	Feb. 29, 2020 USD ($) shares	Jan. 31, 2020 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Dec. 31, 2020 USD ($) $ / shares shares
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized				500,000,000	500,000,000		500,000,000
preferred stock, shares authorized				2,000,000	2,000,000		2,000,000
Common stock shares			2,010,000
Exercise price per share (in Dollars per Share) | $ / shares			0.07
Price per share (in Dollars per share) | $ / shares				$ 0.32	$ 0.32
Stock issued for restricted stock agreement					31,250
Stock value issued for restricted stock agreement (in Dollars) | $					$ 4,550
Common stock, shares issued					1,000,000
Warrant exercise price per share (in Dollars per share) | $ / shares				0.0608	$ 0.0608		$ 0.0627
Exercise per share price (in Dollars per share) | $ / shares					$ 0.40
Shares of exercise of options					1,005,682
Stock value exercise of options (in Dollars) | $					$ 1,090,910
Options exercise price per share (in Dollars per share) | $ / shares				0.32	$ 0.32
Stock based compensation expense (in Dollars) | $					$ 488,847
Reversal of convertible preferred stock dividend accrual (in Dollars) | $					$ 13,602		$ 272,040
Series A convertible preferred stock, liquidation preference (in Dollars per share) | $ / shares				$ 25.00	$ 25.00
Series A convertible preferred stock, dividend rate					6.50%
Weighted average of the last sales prices					95.00%
Liquidation preference					7.50%
Dividend rate increase					10.00%
Preferred stock conversion price per share (in Dollars per share) | $ / shares					$ 12.00
Stockholders equity, description					If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.
Common stock discount shares description					The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.
Reserved a total possible issuance under the plan					50,000,000
Total stock-based compensation expense for grants (in Dollars) | $					$ 488,847	$ 791,000
Stock based Payments description					The $488,847 stock-based compensation for the six months ended June 30, 2021 was comprised of $154,347 option expense and $334,500 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences as well as the recognition of $4,550 for the restricted stock agreements, partially offset by a reversal of $1,000 for the cancellation of 1,000,000 shares.
Restricted stock, grants description					The company issued 140,000 shares through restricted stock grants during the six months ended June 30, 2021 and 2020. The company renewed a consulting agreement, extending services for an additional term of two sequential one-year periods. As compensation for the renewal, Mr. Donaghey is to receive for each year of service during the renewal term 70,000 shares of AERG common stock and options to purchase 200,000 shares of common stock at an exercise price of $0.61 per share, reflecting the fair market value of the common stock on the date of grant. 50% of the options vest on the first anniversary of the renewal, and the other 50% vest on the second anniversary. 50% of the common stock vests immediately and the remaining 50% on the first anniversary of the agreement.
Unrecognized stock based compensation (in Dollars) | $					$ 78,254		$ 0
Business Combination [Member]
Stockholders’ Deficit (Details) [Line Items]
Issuable in acquisition, description					As of June 30, 2021, and December 31, 2020, there was $557,500 and $892,000, respectively, in unrecognized stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 a share as that was the closing price on the date of the contract and is amortized over 36 months. $334,250 and $334,250 was amortized for the six months ended June 30, 2021, and 2020, respectively
Officers and Employees [Member]
Stockholders’ Deficit (Details) [Line Items]
Stock based compensation expense (in Dollars) | $				$ 318,818	$ 351,000
Stock option [Member]
Stockholders’ Deficit (Details) [Line Items]
Options exercise price per share (in Dollars per share) | $ / shares				$ 0.05	$ 0.05
Share-based compensation, options granted					30,809,090
Share-based compensation, options outstanding, weighted average exercise price (in Dollars per share) | $ / shares				$ 0.1485	$ 0.1485
Share-based compensation, options outstanding, weighted average remaining contractual term					5 years 3 months 18 days
Options outstanding aggregate intrinsic value (in Dollars) | $				$ 19,936,090	$ 19,936,090
Unrecognized compensation costs related to unvested equity awards, net of estimated forfeitures (in Dollars) | $				$ 704,749	704,749
Private Placement [Member]
Stockholders’ Deficit (Details) [Line Items]
Stock Issued During Period, Value, New Issues (in Dollars) | $					$ 2,258,000
Subscription Agreements [Member]
Stockholders’ Deficit (Details) [Line Items]
Shares Issued	1,770,333
Subscription Agreements (in Dollars) | $	$ 531,000
Minimum [Member]
Stockholders’ Deficit (Details) [Line Items]
Liquidation preference					1.00%
Maximum [Member]
Stockholders’ Deficit (Details) [Line Items]
Liquidation preference					6.50%
Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Stock Issued During Period, Value, New Issues (in Dollars) | $		$ 510,000	$ 603,000
Common stock shares		1,700,000			7,056,250
Issue of warrants			25,000
Stock issued for convertible notes					158,329
Shares issued for convertible notes (in Dollars) | $					$ 47,499
Common stock, shares issued					250,000
Stock value issued for exercise of warrants				250,000	250,000
Shares issued					259,741
Stock option					500,000
Stock option exercise price Per share (in Dollars per share) | $ / shares					$ 0.37
Warrant [Member]
Stockholders’ Deficit (Details) [Line Items]
Warrant Exercise (in Dollars) | $	$ 11,000
Shares Issued	150,000
Option exercise (in Dollars) | $	$ 63,000
Shares issued	900,000
Common stock, shares issued					800,000
Stock value issued for exercise of warrants				800,000	800,000
Warrant exercise price per share (in Dollars per share) | $ / shares				$ 0.07	$ 0.07
Exercise per share price (in Dollars per share) | $ / shares					$ 0.06
Preferred Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Liquidation preference					101.00%